DC Field | Value | Language |
dc.contributor.author | Abo Arkia, Adan Raed | - |
dc.date.accessioned | 2021-11-05T12:34:46Z | - |
dc.date.available | 2021-11-05T12:34:46Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | ABO ARKIA, Adan Raed. Botulism: life-threatening illness. In: One Health & Risk Management. 2021, vol. 2(suppl.), no. 4, p. 97. ISSN 2587-3466. | en_US |
dc.identifier.issn | 2587-3458 | - |
dc.identifier.issn | 2587-3466 | - |
dc.identifier.uri | https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/issue/view/17/18 | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/18353 | - |
dc.description | Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova | en_US |
dc.description.abstract | Introduction. Botulism is a potentially fatal syndrome of diffuse, flaccid paralysis caused
by botulinum neurotoxin (BoNT), produced by the bacterium Clostridium botulinum. The
toxin is produced as the bacteria multiply; the bacteria multiply under anaerobic and
mildly acidic conditions. The neurotoxin BoNT is considered the deadliest toxin known
due to its high potency and lethality. Based on the different serotypes known today, a classification of serotype variants termed subtypes has been proposed according to sequence
diversity and immunological properties. Authors described seven types of botulinum toxins (A–G), but human botulism is primarily caused by types A, B, E, while types C, D and E
cause illness in other mammals, birds and fish. Most studies demonstrated that antitoxin
should be administered as soon as possible after a clinical diagnosis. There is no vaccination to protect people against botulism. The effective prevention measures of foodborne
botulism are based on good practice of food products preparation and compliance with
basic hygiene rules.
Material and methods. The purpose of the study was to find relevant publications on the
etiology, epidemiology, diagnostic methods and prevention measures of botulism, critically analyze them and describe the research findings. Therefore, a bibliographic review
was performed using online databases as PubMed, Scopus, Web of Science, and Google
Scholar as well as the following keywords C. botulinum, botulism, botulinum neurotoxin
for identifying the evidence published both in the country and abroad.
Results. When analyzing the existing evidence, there was noticed that botulism is a severe
neurological disease caused by the complex family of botulinum neurotoxins that can be
acquired through exposure to the pre-formed toxin via improperly-stored food, iatrogenic
injection, and bioterrorism. Moreover, in infants and wound botulism cases it can be the
result of a systemic release of the toxin in vivo. Most studies have shown that botulism is
an intoxication usually caused by ingestion of potent neurotoxins, the botulinum toxins,
formed in contaminated foods. Person to person transmission of botulism does not occur.
The standard method for rapid diagnosis is positive laboratory findings (detection of
toxin in the patient's serum, feces, gastric, intestinal contents, wound swabs and tissues),
however the clinical manifestations and patient history are also very important. Laboratory rapid diagnosis of botulism is required for successful therapy, considering that it is a
life-threatening condition. This disease can be fatal if left untreated, but most people who
receive a prompt diagnosis and treatment can fully recover from the illness.
Conclusions. The results of many scientific papers have demonstrated that botulism is a
rare but serious condition caused by toxins from bacteria called Clostridium botulinum.
The authors described the principle of diagnosis and showed that it is usually based on
anamnesis and clinical findings followed by laboratory investigations: the presence of
BoNT in serum, stool or food, or a culture of C. botulinum. Also, each case of botulism is
considered a public health emergency and requires immediate report of the suspected
case to the ministry of health or national agency of public health. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Asociația de Biosiguranță și Biosecuritate din Republica Moldova | en_US |
dc.relation.ispartof | One Health & Risk Management: The National Scientific Conference with international participation ”ONE HEALTH” approach in a changing world | en_US |
dc.subject | C. botulinum | en_US |
dc.subject | botulism | en_US |
dc.subject | botulinum neurotoxin | en_US |
dc.title | Botulism: life-threatening illness | en_US |
dc.type | Other | en_US |
Appears in Collections: | One Health & Risk Management Vol. 2 No 4, 2021 Supplement
|